In 2023, an impressive number of nearly 800 million packages of medicines were verified and dispensed in the Polish Drug Authenticity Verification System, while maintaining an average weekly number of 15.2 million. Handling efficiency in the previous year averaged 40.5 million transactions per...
The product in question is a drop used for, among other things, polyps and related symptoms of reduced nasal patency. Production of this specific was most likely completed in May 2023.
A Draft Regulation of the Minister of Health amending the Regulation on defining the list of health care services requiring the establishment of a separate financing method has been submitted for consultation.
January 22 next meeting of the Transparency Council.
On Monday, January 15, the next meeting of the Transparency Council.
Patients with plasmocytic myeloma have gained access to first-line treatment with daratumumab in the DRd regimen (in combination with lenalidomide and dexamethasone). Patients and their physicians have been waiting for this reimbursement decision.
Interview with Prof. Marek Rękas, national consultant for ophthalmology
January 8 next meeting of the Transparency Council.
Takeda Pharma sp. z o.o. in Poland has appointed Sameha Rafla as CEO.
As of January, a decision will take effect that will significantly improve first-line treatment options for plasmocytic myeloma. However, this raises reimbursement challenges for patients with relapsed disease. The most pressing need is to include the KDd regimen in second-line reimbursement.
We discuss the treatment of severe asthma with Prof. Maciej Kupczyk, president of the Polish Society of Allergology (Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz).
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has published a positive opinion for omaweloxolone, the first therapeutic solution to treat Friedreich's ataxia, a rare neurodegenerative disease.
People struggling with allopecia experience stigma and have huge problems with self-acceptance. This is all the more dangerous because the onset of the disease most often occurs during puberty, when not only the body matures, but also the psyche of a young person is formed. Medical advances have...
The co-author of the report "Report B.44. Treatment of Patients with Severe Asthma," Dr. n. econ. speaks about the cost of treating severe asthma. Michal Seweryn.
During the session, it was planned:Preparation of a position paper on the evaluation of the drug Mizetam (ezetimibum + atorvastatin) in the indication: prevention of cardiovascular events, i.e. as replacement treatment in patients with coronary heart disease (CHD, Coronary Heart Disease) and...
The most important event of 2023 for us was the amendment of the Reimbursement Law. Unfortunately, until today, modest provisions supporting the production of medicines and active substances have not been implemented. We are not taking advantage of the potential of the domestic pharmaceutical...
Is it too late to urge Poles to get the flu vaccination? The patient's path to this vaccination is complicated. We will talk about all sorts of organizational barriers that make the level of implantation in Poland leave much to be desired.
The European Commission, together with the European Medicines Agency and the heads of member states' medicines agencies (HMAs), today published the first EU list of critical medicines. Today's publication follows a commitment in the Commission's Communication on tackling drug shortages in the EU...
In the first list effective in 2024, public funding was provided for 19 newmolecule-indications, including:8 molecule - oncology indications,11 molecule - non-oncology indications,10 molecule indications dedicated to rare diseases.The reimbursement notice effective January 1, 2024 (No. 73),...
During the session, it was planned:Preparation of a position paper on assessing the appropriateness of qualifying the health care service "Pharmaceutical care" as a guaranteed benefitPreparation of an opinion on the use of hyperthermia treatment in cancer diseasesPreparation of an opinion on the...
As of November 1, 2023, patients should pay less at pharmacies for reimbursed drugs made in Poland or from Polish ingredients. Meanwhile, the health ministry has not published a list of drugs covered by the reduction, and it is not included in the draft announcement that will be in effect from...
An interview with Prof. Marcin Czech of the Mother and Child Institute, president of the Polish Pharmacoeconomic Society.
The Draft Announcement of the Minister of Health on the List of Reimbursed Drugs, Foodstuffs for Special Dietary Purposes and Medical Devices, which will come into effect on January 1, 2024, has been published.
The OJ of the Ministry of Health published a Notice of the Minister of Health dated December 7, 2023 on the list of medicinal products, foodstuffs for special nutritional purposes and medical devices at risk of unavailability on the territory of the Republic of Poland.
However, funding is needed!
Doctors of the Healthcare Employers' Agreement are appealing to Minister Ewa Krajewska to make public information about the shortage of vaccines against COVID-19 Novavax-Nuvaxovid XBB.1.5 - The situation of shortage of vaccines with simultaneous media campaign results in a huge number of phone...
In recent years, tremendous progress has been made in the diagnosis and treatment of spinal muscular atrophy. This consists of a newborn screening program and a drug program that includes three therapies, including gene therapy. Thanks to the possibility of implementing treatment as early as the...
An interview with Deputy Health Minister Maciej Miłkowski.
The Economic Commission was joined by representatives of the Health Ministry Sylwia Kacprzykowska, Katarzyna Klimkowska, Lukasz Kucharenko, Pawel Tobiaszewski.The Economic Commission is a team that conducts price negotiations with applicants for reimbursement of drugs, foodstuffs for special...
Interview with Zbigniew Pawlowski, president of the Association of Families of Patients with Amyloidosis.
© 2023 Medexpress. All Rights Reserved